Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to GM-CSF
Related studies linked through entity extraction aliases.
Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Vaccine Therapy and GM-CSF With or Without Low-Dose Aldesleukin in Treating Patients With Stage II, Stage III, or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Herceptin and GM-CSF for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)
- Status
- TERMINATED
- Phase
- PHASE2
Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Cellular Immune Augmentation in Colon and Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Treatment of Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF
- Status
- TERMINATED
- Phase
- PHASE2
Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Randomized Trial of GM-CSF in Patients With ALI/ARDS
- Status
- COMPLETED
- Phase
- PHASE2